Mira Pharmaceuticals Files 8-K for Other Events
Ticker: MIRA · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-event, filing
TL;DR
Mira Pharma filed an 8-K for 'other events' - details TBD.
AI Summary
Mira Pharmaceuticals, Inc. filed an 8-K on August 19, 2025, to report other events. The company, formerly known as Mira1a Therapeutics, Inc. until January 12, 2022, is incorporated in Florida and headquartered in Miami. The filing does not disclose specific details about the 'other events' but serves as a notification to the SEC.
Why It Matters
This filing indicates a corporate event has occurred that requires disclosure, though the specific nature of the event is not detailed in this summary.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure without immediate financial or operational impact detailed.
Key Players & Entities
- MIRA PHARMACEUTICALS, INC. (company) — Registrant
- Mira1a Therapeutics, Inc. (company) — Former Company Name
- August 19, 2025 (date) — Date of Report
- Florida (location) — State of Incorporation
- Miami (location) — Principal Executive Offices City
FAQ
What specific 'other events' are being reported by Mira Pharmaceuticals, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'other events' being reported, only that the filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for 'Other Events'.
When was Mira Pharmaceuticals, Inc. formerly known as Mira1a Therapeutics, Inc.?
Mira Pharmaceuticals, Inc. was formerly known as Mira1a Therapeutics, Inc. until January 12, 2022.
Where are Mira Pharmaceuticals, Inc.'s principal executive offices located?
Mira Pharmaceuticals, Inc.'s principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.
What is the SEC file number for Mira Pharmaceuticals, Inc.?
The SEC file number for Mira Pharmaceuticals, Inc. is 001-41765.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is August 19, 2025.
Filing Stats: 658 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-08-19 08:00:37
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001641172-25-024731.txt ( ) — 202KB
- mira-20250819.xsd (EX-101.SCH) — 3KB
- mira-20250819_lab.xml (EX-101.LAB) — 33KB
- mira-20250819_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: August 19, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer